MedTrace Logo

Early Anti-Retroviral Treatment in HIV- Infected Children

NCT05784584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2024-12-30

No results posted yet for this study

Summary

EARTH study is conducted as part of the EPIICAL project. It is a prospective cohort study which aims to monitor clinical, virological and immunological features of HIV-positive, early treated children (≤90 days after diagnosis), in order to identify participants with excellent viral and immunological control, and also other without excellent control, in order to stratify potential participants in proof-of-concept trials directed to HIV cure.

Conditions

  • HIV Infections

Interventions

PROCEDURE

Blood samples collection

The study population will take blood samples for virological and immunological measurements.

Sponsors & Collaborators

  • PENTA Foundation

    lead NETWORK

Principal Investigators

  • Alfredo Tagarro, MD · Fundación Investigación Hospital 12 de Octubre

Eligibility

Max Age
180 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2024-02-28
Completion
2024-03-28

Countries

  • Mali
  • Mozambique
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784584 on ClinicalTrials.gov